INVITRO SUSCEPTIBILITY OF AEROBIC GRAM-NEGATIVE BLOOD CULTURE ISOLATES TO OXOLINIC ACID, NORFLOXACIN, CIPROFLOXACIN, ENOXACIN, PEFLOXACIN, OFLOXACIN AND OXO-ENOXACIN

被引:5
作者
VANDERAUWERA, P [1 ]
机构
[1] INST JULES BORDET,INVEST LAB,B-1000 BRUSSELS,BELGIUM
关键词
D O I
10.1007/BF01643481
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:142 / 144
页数:3
相关论文
共 20 条
[1]  
ADHAMI Z, 1983, J ANTIMICROB CHEMOTH, V13, P87
[2]   INVITRO ACTIVITY OF CIPROFLOXACIN, NORFLOXACIN AND NALIDIXIC-ACID [J].
BAUERNFEIND, A ;
PETERMULLER, C .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1983, 2 (02) :111-115
[3]  
CROIZE J, 1985, PATHOL BIOL, V33, P564
[4]   PHARMACOKINETICS AND TISSUE PENETRATION OF CIPROFLOXACIN [J].
CRUMP, B ;
WISE, R ;
DENT, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 24 (05) :784-786
[6]  
Gavan T. L., 1980, MANUAL CLIN MICROBIO, P459
[7]   MULTIPLE-DOSE PHARMACOKINETICS AND SAFETY OF CIPROFLOXACIN IN NORMAL VOLUNTEERS [J].
GONZALEZ, MA ;
URIBE, F ;
MOISEN, SD ;
FUSTER, AP ;
SELEN, A ;
WELLING, PG ;
PAINTER, B .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 26 (05) :741-744
[8]   COMPARATIVE INVITRO ACTIVITIES OF AZTREONAM, CIPROFLOXACIN, NORFLOXACIN, OFLOXACIN, HR-810 (A NEW CEPHALOSPORIN), RU28965 (A NEW MACROLIDE), AND OTHER AGENTS AGAINST ENTEROPATHOGENS [J].
GOOSSENS, H ;
DEMOL, P ;
COIGNAU, H ;
LEVY, J ;
GRADOS, O ;
GHYSELS, G ;
INNOCENT, H ;
BUTZLER, JP .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 27 (03) :388-392
[9]  
GRIMM H, 1985, ARZNEIMITTEL-FORSCH, V35-1, P570